Aprepitant Kit
Product Images NDC 13668-594

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aprepitant (NDC 13668-594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 01)

Chemical structure of the active ingredient Aprepitant, showing its molecular framework with multiple rings, fluorine, trifluoromethyl, and oxygen-containing groups.*

FDA Label Image

Figure 1 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 02)

Two line graphs labeled Study 1 and Study 2 compare the percentage of patients over time (up to 120 hours) between an Aprepitant regimen and a standard therapy. Both studies show higher patient percentages maintained over time with Aprepitant. A p-value less than 0.001 is noted for the comparisons based on a log rank test.*

FDA Label Image

Figure 2 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 03)

Bar charts from two studies comparing the percent of patients receiving Aprepitant regimen versus standard therapy across six chemotherapy cycles. The y-axis shows percent of patients, and the x-axis lists chemotherapy cycles 2 through 6. Patient counts for each group and cycle are provided below each chart. The data visually compares patient retention in each treatment group by cycle.*

FDA Label Image

Figure 3 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 04)

A line graph comparing the percentage of patients over time (in hours) for two treatments: Aprepitant 40 mg and Ondansetron. The y-axis represents the percent of patients, and the x-axis represents hours from 0 to 48. The solid line corresponds to Aprepitant 40 mg (N=292) and the dotted line to Ondansetron (N=279), showing trends in patient response over a 48-hour period.*

FDA Label Image

Torrent Logo (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 05)

FDA Label Image

Logo (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 06)

FDA Label Image

40 mg (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 07)

Aprepitant Capsules, USP 40 mg packaging label showing a box design for 5 capsules. The label indicates the product is a prescription drug containing 40 mg aprepitant per capsule. It is manufactured by Pharmathen International S.A., Greece, and labeled by Torrent Pharma Inc. The label includes storage instructions and the NDC number 13668-591-82.*

FDA Label Image

80 mg (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 08)

Packaging label for Aprepitant Capsules, USP 80 mg by Torrent Pharmaceuticals Limited. The label indicates the product is oral capsules supplied in a 6-capsule bulk package. It includes usage age information (12 years and older), storage instructions, and manufacturer details for Pharmathen International S.A. and Torrent Pharma Inc. The NDC is partially visible as 13668-592.*

FDA Label Image

125 mg (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 09)

Packaging label for Aprepitant Capsules, USP 125 mg, an oral capsule prescription drug. The label indicates the product contains 6 capsules, is for adults and pediatric patients 12 years and older, and notes the package is a bulk package not intended for dispensing. Manufactured by Pharmathen International S.A. and labeled for Torrent Pharmaceuticals Limited. Storage instructions and barcode are also visible.*

FDA Label Image

Kit (80 mg + 125 mg) (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 10)

Aprepitant Capsules, USP 125 mg / 80 mg oral capsules packaging label by Torrent Pharmaceuticals Limited. The label shows a 3-day pack containing 3 capsules: one 125 mg capsule and two 80 mg capsules. It includes dosing instructions for use with chemotherapy and storage conditions, with the manufacturer's details listed as Pharmathen International S.A., Greece, and the labeler as Torrent Pharma Inc., Pennsylvania.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.